Angitia Biopharmaceuticals
Phase 2ANGITIA - INNOVATION FOR PATIENTS
Founded
2021
Focus
AntibodiesBiologics
About
ANGITIA - INNOVATION FOR PATIENTS
Funding History
6Total raised: $540M
Series D$130MUndisclosedFeb 5, 2026
Series C$120MUndisclosedDec 11, 2024
Series B$80MF-Prime CapitalMar 15, 2023
Series B$100MCormorant Asset ManagementJan 15, 2023
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile